Advertisement

News

FDA Publishes Final Rule on Designation of New Animal Drugs for Minor Uses or Minor Species

The Food and Drug Administration has issued final regulations, in response to the Minor Use and Minor Species Animal Health Act of 2004 (MUMS act)

August 2, 2007


FDA Publishes Final Rule on Designation of New Animal Drugs for Minor Uses or Minor Species

 

The Food and Drug Administration (FDA) issued final regulations, in response to the Minor Use and Minor Species Animal Health Act of 2004 (MUMS act) July 26. 

 

The MUMS act amended the Federal Food, Drug, and Cosmetic Act by, among other things, establishing section 573 to establish new regulatory procedures that provide incentives intended to make more drugs legally available to veterinarians and animal owners for the treatment of minor animal species and uncommon diseases in major animal species. 

 

This act parallels similar legislation passed under the Orphan Drug Act for humans.  FDA published a proposed rule in the Federal Register of December 28, 2005 (70 FR 76732) to implement these new procedures.  FDA has evaluated all public comments received in response to the proposed rule and is issuing final regulations to implement the act.

 

The final rule implements section 573 of the MUMS act and describes the procedure for designating a new animal drug as a minor use or minor species drug.  MUMS designation of a new animal drug will allow drug sponsors to be granted seven years of exclusive marketing rights for these limited demand new animal drugs to encourage the development of drugs for minor uses or in minor animal species.

 

This regulation will define content and format requirements for designation requests as well as provisions for amending requests changing designation ownership, and annual reporting requirements.  This rule will also describe the criteria the Center for Veterinary Medicine (CVM) will use for granting or denying these requests.  Specific sections of the rule will be dedicated to verification of MUMS status in a request, granting MUMS designation, and revocation of MUMS designation.

 

The final rule was published in the  July 26, 2007, Federal Register.  It will become effective on October 9, 2007.

 

 Questions may be directed to Dr. Bernadette Dunham, CVM, FDA,

7519 Standish Pl., Rockville, MD 20855
, 240-276-9090, Bernadette.Dunham@fda.hhs.gov.

 

For additional information on animal drugs for minor uses and minor species, please see http://www.fda.gov/cvm/minortoc.htm.

 

Related articles

 

USA - NAA Requested Extension for Comments on MUMS Indexing
30 day extension of the comment period requested for Index of Legally Marketed Unapproved New Animal Drugs for Minor Animal Species more

 

FDA Issues Proposed Regulations for MUMS Indexing
FDA is issuing proposed regulations for administrative procedures and criteria for index listing a new animal drug for use in a minor species - a basis for legally marketing an unapproved new animal drug intended for use in a minor species. (Comments invited). more

 

American Feed Industry Association welcomes catfish drug approval
AFIA welcomes first new drug for U.S. aquaculture in 20 years; will help users to understand requirements for use more

 

MUMS drug approval bill passes Subcommittee
The bill brings the availability of badly needed aquatic animal health products a step closer

more

 

MUMS drug approval bill passes Subcommittee
The bill brings the availability of badly needed aquatic animal health products a step closer

more

Advertisement

Latest Magazine

Job Opportunities